Retour
Fourchette du Jour
3,03 €
3,28 €
Fourchette 52 Semaines
3,03 €
11,85 €
Volume
1 130 277
Moyenne 50J / 200J
4,53 €
/
6,85 €
Clôture Précédente
3,33 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,2 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -47,4 | 3,8 |
| Rev Growth 5Y % | 64,7 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
8,60 €
+174.8%
Low: 5,00 €
High: 10,00 €
P/E Prévisionnel
37,0
BPA Prévisionnel
0,09 €
Croissance BPA (est.)
+0,0%
CA Est.
640 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,08 €
1,62 € – 2,49 €
|
1,7 B | 1 |
| FY2029 |
1,17 €
0,91 € – 1,40 €
|
1,4 B | 1 |
| FY2028 |
0,56 €
0,15 € – 0,97 €
|
1 B | 2 |
Points Clés
Revenue grew 64,66% annually over 5 years — strong growth
Negative free cash flow of -293,84M
PEG of 0,24 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 370,90%
Interest coverage of 0,44× — tight debt servicing
Croissance
Revenue Growth (5Y)
64,66%
Revenue (1Y)435,56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC6,72%
Net Margin-47,35%
Op. Margin14,22%
Sécurité
Debt / Equity
N/A
Current Ratio2,35
Interest Coverage0,44
Valorisation
P/E Ratio
-4,21
P/B RatioN/A
EV/EBITDA30,36
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 435,56% | Revenue Growth (3Y) | 142,85% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 64,66% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 489,68M | Net Income (TTM) | -231,86M |
| ROE | N/A | ROA | -18,98% |
| Gross Margin | 62,16% | Operating Margin | 14,22% |
| Net Margin | -47,35% | Free Cash Flow (TTM) | -293,84M |
| ROIC | 6,72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,35 |
| Interest Coverage | 0,44 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,21 | P/B Ratio | N/A |
| P/S Ratio | 1,99 | PEG Ratio | 0,24 |
| EV/EBITDA | 30,36 | Dividend Yield | 0,00% |
| Market Cap | 975,31M | Enterprise Value | 2,11B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 489,68M | 91,43M | 83,03M | 36,77M | 66,62M |
| Net Income | -231,86M | -551,73M | -513,58M | -101,50M | -170,04M |
| EPS (Diluted) | -0,87 | -2,43 | -2,60 | -3,25 | -5,44 |
| Gross Profit | 304,37M | -69,42M | 18,93M | 36,77M | 66,62M |
| Operating Income | 69,64M | -354,86M | -346,44M | -235,46M | -137,54M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,22B | 950,09M | 828,44M | 597,98M | 474,42M |
| Total Liabilities | 1,63B | 1,88B | 1,39B | 733,59M | 1,34B |
| Shareholders' Equity | -412,77M | -932,49M | -564,42M | -135,61M | -867,24M |
| Total Debt | 1,19B | 1,08B | 805,10M | 523,05M | 676,85M |
| Cash & Equivalents | 51,43M | 11,16M | 66,43M | 17,56M | 31,69M |
| Current Assets | 455,02M | 194,84M | 230,74M | 119,82M | 86,16M |
| Current Liabilities | 193,40M | 260,95M | 167,29M | 111,84M | 50,98M |